British Journal of Oral and Maxillofacial Surgery
Volume 44, Issue 6 , Pages 501-503, December 2006

Bupivacaine as pre-emptive analgesia in third molar surgery: Randomised controlled trial

  • M. Sharif Nayyar

      Affiliations

    • National Maxillofacial Unit, Registrar Maxillofacial Unit, St James Hospital, Dublin 8, Republic of Ireland
    • Corresponding Author InformationCorresponding author. Tel.: +353 1 4162352; fax: +353 1 4162055.
    • ,
  • C. Yates

      Affiliations

    • Wexham Park Hospital Slough, SL2 4HL England, UK
    • Tel.: +44 1753 633000; fax: +44 1753 634076.

Accepted 7 September 2005.

Abstract 

We conducted a prospective, randomised study on the use of pre-emptive analgesia in 45 patients who had bilateral impacted third molars removed. Bupivacaine 0.5% with adrenaline 1:200,000 was injected on one side, the other side acting as control. A visual analogue scale was used to measure the extent of postoperative pain. There was a significant reduction (p=0.05) in postoperative pain on the injected side at 6, 12, and 72h and an overall reduction in pain up to 7 days.

Keywords: Prospective, Randomised, Pre-emptive analgesia, Wisdom tooth, Bupivacaine, Visual analogue scale

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0266-4356(05)00299-8

doi:10.1016/j.bjoms.2005.09.012

British Journal of Oral and Maxillofacial Surgery
Volume 44, Issue 6 , Pages 501-503, December 2006

Article Tools

* Image Usage & Resolution